As of 20 June 2025, the Health Technology Assessment (HTA) Council has completed the evidence appraisal on the assessment of newborn pulse oximetry as a screening test for critical congenital heart disease (CCHD) among asymptomatic, apparently healthy newborns for possible government financing. The HTA Council hereby releases its preliminary recommendation on the said health technology continue reading : HTA Council Preliminary Recommendation on Newborn Pulse Oximetry as a Screening test for critical congenital heart disease (CCHD) among asymptomatic, apparently healthy newborns